share_log

TransCode Therapeutics Collaborates With Debiopharm; Financial Terms Not Disclosed

Moomoo 24/7 ·  Jan 29 08:40

The collaboration will explore combining TransCode's proprietary TTX delivery platform with Debiopharm's expertise in targeted drug delivery to co-develop targeted nucleic acid therapeutics for cancer.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment